Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-6 of 6 for your search:
Drug:
yttrium Y 90 monoclonal antibody MN-14
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase I/II Study of Radioimmunotherapy with Yttrium Y 90 Monoclonal Antibody MN-14 With or Without Doxorubicin Plus Peripheral Blood Stem Cell Rescue in Patients with Medullary Thyroid Carcinoma
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Closed
Age:
16 to 80
Sponsor:
Other
Protocol IDs:
CMMI-C-040A-98
, CMMI-FDR001555, NCI-V99-1564, NCT00004048
2.
Phase I/II Study of High-Dose Radioimmunotherapy With Yttrium Y 90 Monoclonal Antibody MN-14 Plus Peripheral Blood Stem Cell Rescue in Patients With Stage IV Breast Cancer
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
CMMI-C-041A-98
, NCI-H99-0039, NCI-V99-1568, NCT00004085
3.
Phase I/II Study of High Dose Radioimmunotherapy with Yttrium Y 90 Monoclonal Antibody MN-14 Plus Autologous Peripheral Blood Stem Cell Rescue in Patients with Advanced Ovarian Epithelial Cancer
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Closed
Age:
18 to 80
Sponsor:
NCI
Protocol IDs:
CMMI-C-039A-98
, NCI-H99-0044, NCI-V99-1570, NCT00004177
4.
Phase I/II Study of High Dose Radioimmunotherapy with Yttrium Y 90 Monoclonal Antibody MN-14 Plus Autologous Peripheral Blood Stem Cell Rescue in Patients with Metastatic or Recurrent Colorectal Cancer or Pancreatic Cancer
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Closed
Age:
18 to 80
Sponsor:
NCI
Protocol IDs:
CMMI-C-033-98
, NCI-H99-0042, NCI-V99-1571, NCT00004087
5.
Phase I Study of Yttrium Y 90 Anti-CEA Monoclonal Antibody MN-14 in Patients With Relapsed or Refractory Non-Small Cell Lung Cancer
Phase:
Phase I
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
CMMI-C-047A-99
, NCI-H00-0063, NCT00006458
6.
Phase I Study of Yttrium Y 90 Anti-CEA Monoclonal Antibody MN-14 in Patients With Relapsed or Refractory Small Cell Lung Cancer
Phase:
Phase I
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
CMMI-C-057A-99
, NCI-H00-0064, NCT00006347
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute